Navigation Links
Mental retardation linked to brain protein

The journal, Proceedings of the National Academy of Science, recently published a study by researchers from Oregon Health and Science University, which said that a brain protein called WAVE-1 may play a key role in mental retardation. WAVE-1 is a protein that is found throughout the brain and plays an important role in brain cell communication. The research was carried out on mice that were produced, without the WAVE-1// protein, by the researchers . It was found that these mice had balance, motor, learning and memory problems and the symptoms in these mice without WAVE-1, correlate with one form of human mental retardation. The researchers believe the absence of the WAVE-1 protein causes a partial breakdown of the brain cell communication system, that results in reduced learning ability and other problems associated with mental retardation.

The study presented the major conclusion that mental retardation involves many more areas of the brain than first expected and this research conducted on mice may provide information to help scientists better understand mental retardation and to develop new drugs or therapies to counter the condition.


'"/>




Page: 1

Related medicine news :

1. Mental illness a key factor in suicide
2. Mental growth in babies at risk
3. Reduced Fatigue Boosts Mental Health
4. Mental Health Services for Children
5. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
6. Diabetics To Seek Mental Counseling To Cope With Stress
7. Exercise Can Decrease Mental Decline
8. Low Socioeconomic Status May Lead To Mental Illness
9. Mental health may deteriorate as early as in the teens
10. Folic Acid Retards Mental Decline In Middle Aged Subjects
11. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... analytics to its patient care management module. Using this new feature, sleep physicians ... has been initiated on continuous positive airway pressure (CPAP), oral, or other forms ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: